Drug Shortage Report for PRIVA-GABAPENTIN
| Report ID | 62805 |
| Drug Identification Number | 02450127 |
| Brand name | PRIVA-GABAPENTIN |
| Common or Proper name | GABAPENTIN 600MG |
| Company Name | PHARMAPAR INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 600MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2018-10-01 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2018-10-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1565 BOUL LIONEL-BOULET VARENNES, QUEBEC CANADA J3X 1P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2018-10-02 | English | Compare |
| v2 | 2018-10-01 | French | Compare |
| v1 | 2018-10-01 | English | Compare |
Showing 1 to 3 of 3